Studies of severe, monogenic forms of language disorders have revealed important insights into the mechanisms that underpin language development and evolution. It is clear that monogenic mutations in genes such as FOXP2 and CNTNAP2 only account for a small proportion of language disorders seen in children, and the genetic basis of language in modern humans is highly complex and poorly understood. In this review, we examine why we understand so little of the genetic landscape of language disorders, and how the genetic background of an individual greatly affects the way in which a genetic change is expressed. We discuss how the underlying genetics of language disorders has informed our understanding of language evolution, and how recent advances may obtain a clearer picture of language capacity in ancient hominins.
Introduction
The ease with which most children acquire their native language has lead researchers to propose that language acquisition is innate, 1 , and suggest that this reflects a genetically determined languagespecific module 2 . Others argue that it simply reflects higher order processing in humans and is facilitated by their existing cognitive skills 3 . Major questions remain as to the evolutionary and genetic mechanisms that underpin these proposed models; did language evolution rely upon a small number of 'big-hit' mutations which rapidly changed cognition, or through a series of small-step changes where many variants were accumulated slowly over thousands of years? Did ancient hominins have the cognitive ability to use some form of language?
The study of genetic variation that underpins language ability in modern humans can provide insights into how higher language function evolved in our ancient ancestors. The application of next generation sequencing technology means that we are now able to generate a near-complete picture of genetic variation with relative ease. The discovery of genetic variants associated with language disorders results in the identification of the genes and molecular pathways necessary for the successful acquisition of language. Genetic studies of modern humans, therefore, have direct relevance to the study of how language evolved in our ancestors.
Discussion of the evolution of language in fields outside of genetics, still tend to consider 'a gene for language' as the principle driver of language evolution. While the consideration of single variants and genes has provided important insights, the field of human genetics has moved on. Here, we argue that in order to understand language evolution, we first need to consider the full genetic landscape in modern humans, then use this to inform our understanding of the forces that shaped language evolution in ancient hominins.
Language Disorders
When considering which genetic pathways contribute to language, researchers often choose to study the extremes of language ability -most often when a person's ability to speak is severely impaired. So 3 far, the greatest insights into the molecular biology of language have come from studying the genetics of families and individuals with persistent language disorders.
A recent study found that over 7% of British children (n=12,000, Surrey) at school entry had impaired language, either as part of a complex developmental disorder such as autism spectrum disorder (ASD), developmental delay or intellectual disability, or as a primary language disorder with no other explanatory features 4 . Previous smaller English speaking studies concluded similar rates 5; 6 . In real terms, this means that a staggering three children in every class have a language disorder 4 . Age appropriate language acquisition is so important to a child's development that receptive language ability at age 3 is a predictor of an individuals' future economic burden 7 . Despite educational intervention, over half of children with language disorders have lasting difficulties with language throughout their childhood 8 . This means that a child who struggles to understand or produce language, even from an early age, has an increased risk of behavioural disorders, unemployment and mental health issues later in life 9 . This importance is clearly demonstrated in a recent systematic review which found that there was a consistent strong association between young offenders and language disorders 10 .From a genetics point-of-view, it is of particular interest when language disorder occurs in isolation (so-called primary language disorder), with no other features such as autism spectrum disorder or developmental delay that may confound difficulties with language. Primary language disorders may represent domain independent deficits and therefore provide an excellent opportunity to study the genetics that underpin speech.
Two such primary language disorders are childhood apraxia of speech (previously called developmental verbal dyspraxia) (CAS, OMIM #602081) and developmental language disorder (DLD) (also known as specific language impairment) (SLI, OMIM %606711, %606712, %607134, %612514). Although both conditions are primary language disorders, they are proposed to arise from different obstacles in language production pathways. CAS is primarily a motoric difficulty in which the brain cannot coordinate the fine muscles controlling the tongue, lips and mouth that are required to produce speech 6 . DLDs are a persistent difficulty with more generalised aspects of speech and 4 language, in the absence of any other explanatory medical condition such as hearing difficulties or developmental delay 11 . The diagnostic guidelines for DLDs are therefore less stringent than CAS and, accordingly, DLDs are an extremely common childhood developmental issue that can persist throughout the child's life. In this review we will focus on the primary language disorders DLD and CAS.
There is little doubt as to the impact of language disorders on children, but despite the frequency and impact on society, we still understand little of the underlying neurobiology. It is clear that the risk of speech and language disorder is increased if a parent or sibling has a speech disorder 12 . Many studies indicate that language ability is highly heritable, and that that genetic factors play a role in this familiality [12] [13] [14] . The identification of genetic variants or risk factors for DLDs may explain why some children struggle with language acquisition. It may also help explain why language ability is so often affected in related disorders such as ASD, developmental dyslexia, intellectual learning disability or attention deficit hyperactivity disorder (ADHD) and tease apart the phenotypic overlaps between these highly related disorders. Assuming that language impairments are at one end of a continuum of language ability, genetic studies are providing a better understanding of the molecular pathways that are important in language acquisition.
Genes Involved in Disorders of Language Development
When a language disorder recurs within multiple generations of a family, we often assume a strong genetic contribution. Such families have therefore traditionally been the obvious place to start when studying genetic inheritance. The principal insights into the genetics of DLDs have come from such family studies, and several genes have been identified using genetic linkage and candidate gene sequencing in related family members (Table 1) . These genes were often identified from single families or a number of related individuals, using genetic linkage to look for regions of the genome shared by language impaired family members, or by testing for genetic association between large numbers of unrelated individuals with a similar phenotype ( , and as such, causative mutations in FOXP2 are still considered a rare cause of language disorders.
FOXP2, dubbed a 'molecular window' into speech and language development, has been a leap-pad for the identification of other genes and mechanisms involved in language (for example, CNTNAP2
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, as described below). The discovery of FOXP2 was hailed by the media as the 'speech gene' -suggesting that this single protein is responsible for language development in humans. This headline tag is an overly simplistic interpretation, which has endured in fields outside of genetics and language biology. More recently, investigation into the molecular function of FOXP2 has slowly built a more detailed picture of its role in language development [18] [19] [20] . The literature is clear -FOXP2 is not the sole explanatory factor for presence of language. 
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There are very few instances of monogenic inheritance, where the absence of a protein leads directly to language disorder. In Table 1 , only FOXP2, FOXP1 and TM4SF20 have been described as monogenic drivers of language disorders. The remainder of the identified genes instead confer risk of language disorder through genetic variations that subtly alter the way in which genes and proteins work. The majority of genes have been implicated in language disorders through association with language-related phenotypes obtained from cohort studies. In contrast to FOXP2, where a mutation explains the observed language difficulties (monogenic model), these genes tend to play a role within a complex genetic model. Carrying a risk variant within these genes confers a 'susceptibility' to develop language disorder, however this remains difficult to quantify and is poorly understood.
Nonetheless, the study of cases and their families has provided an important window into the underlying mechanisms of language disorders. At present, FOXP2 and FOXP1 remain the best characterised of the genes implicated in language disorders. Clinical diagnosis of the underlying molecular cause of a language disorder is not usually possible, unless the causative mutation is within FOXP2, FOXP1 or TM4SF20. Mutations in these genes are rare, and therefore the majority of language disorder cases are unlikely to have an underlying molecular cause identified.
Large scale genome sequencing projects such as 1000 Genomes 62 and ExAC 63 have created a major shift in how we perceive human genetic variation and its contribution to disease. We have understood for decades that monogenic disorders usually involve rare mutations which impact upon the function of the protein. Such mutations usually lead to non-functional proteins which manifest in a disease phenotype. Access to large numbers of control genomes through 1000 Genomes and ExAC has enabled us to more accurately identify and assess genetic risk factors, which tend to be more common in the population, but may confer a modest risk of developing a phenotype. we now understand the importance of considering all variation on a genetic background.
Complex Inheritance and Genetic Risk
The power of familial studies are a proven method to identify contributory genes, but increasingly molecular genetics is focussing on the role of modifiers and risk factors in DLDs. The majority of genes listed in Table 1 America, suggesting that it may confer susceptibility to DLD when inherited in combination with other variants that are yet to be identified.
The study of complex genetic factors is primarily performed using large numbers of unrelated cases specifically selected to have a high degree of phenotypic similarity. Large scale genome-wide association studies (GWAS) with several thousands of participants may be able to successfully 10 identify common risk variants involved in DLDs, however a large scale study of this nature has not yet been attempted. A recent GWAS into the genetic basis of schizophrenia successfully identified more than 100 associated loci using 37,000 schizophrenia patients and 113,000 controls 66 . The application of these methods in clinical traits such as schizophrenia, have shown that enormous sample sizes are required to enable the consistent replication of associated loci.
A major limiting factor in performing a large scale GWAS for language disorders remains the systematic phenotyping of enough participants to gain the statistical power required to detect contributory variants. This challenge is common to most large complex genetics studies, but is particularly pronounced for the field of language disorders where there is little consensus on what constitutes a speech and language disorder, or how it should be diagnosed and classified. A recent report by the CATALISE consortium aims to do exactly that
11
. Even the terminology used to describe language disorders and DLDs required standardisation across disciplines, and although these are the current approved terms, they are taking time to become standard in research and education.
Establishing consistent terminology is the keystone to developing standardised diagnostic criteria.
Once these definitions are consistent within and across disciplines, then a large scale study could be successfully developed. It would likely lead to the identification of a novel pathways and gene networks involved in language production. This observation suggests the documented phenotypic overlap between developmental disorders like DLD, ASD, and dyslexia may be driven by shared genetic aetiology. We should note, however that the level of shared aetiology is hard to objectively ascertain without genome-wide data. Technical and financial limitations mean that many studies of DLDs to date are limited to candidate genes, leading to substantial ascertainment bias.
The factors that determine how a given genetic variant manifests to become one phenotype over another is not fully understood, but they are likely to involve interactions between genetic variants.
This emphasises the need to consider the genetic background of an individual within any candidate gene analyses. These multiple layers of complexity partly explain why genetic studies have so far struggled to elucidate the genetic basis of many neurodevelopmental disorders.
Limitations of current genomic studies
There are a number of reasons why we do not have a better picture of the genetics of speech and language disorders. As discussed above, the majority of studies have used relatively low resolution mapping methods within small sample sizes with inconsistent characterisation between studies.
Recent advances in DNA sequencing technology allow us to generate a more complete picture of genetic variation across the entire genome (whole genome sequencing) or across all known genes in the genome (whole exome sequencing). Whilst such technologies afford better resolution and, to some extent, offset these problems, the identification of risk variants, which only have a small effect size, remain difficult.
The average human genome contains between 4 and 5 million variants that differ from published reference sequences. Only about 1% of the human genome actually encodes genes, and these gene encoding regions will contain about 150 coding mutations which result in the loss-of-function of the 12 protein. They will also contain around 10,000 'silent' mutations that fall within genes but do not alter the amino sequence. Each person's genome will contain about 120 novel coding variants which have not previously been reported 62 . The vast majority of variation we see in the human genome does not directly change the protein, and is non-coding. Once we consider that these non-coding changes may have a function affecting gene expression (how much of each protein is made), the list of potential variants can be vast, and extremely challenging.
Exome sequencing studies investigate just the coding regions of the genes of individuals affected by DLD 35; 59 or CAS 16 . These preliminary, small-scale investigations confirm the complexity of the underlying genetics in the majority of cases and reinforce the need for larger-scale screening studies.
Even though they lie outside of gene sequences, non-coding variants can change gene functions, for example by increasing or decreasing expression. It is highly likely that these non-coding variants will be involved in neurodevelopmental disorders. These variants represent a far greater challenge than coding variants. They are often not captured by whole exome sequencing meaning that we may simply be missing important mutations. Whole genome sequencing is becoming more commonly used, but cost is often prohibitively expensive. Even when these variants are captured, their categorisation is difficult. A recent study demonstrated a role for variations within non-coding regulatory regions in DLD and other neurodevelopmental conditions underlining the importance of this route of investigation 22 . The use of whole genome sequencing produces vastly more data, and analysis can be more computationally expensive, and requires a much greater level of analytical expertise. Since the effects of these variants are often indirect, their characterisation usually involves complex functional validation steps that are challenging to complete for a high number of variants.
Genetic studies tend to be performed on European or American cohorts. Findings in these participants may not be relevant in other populations as some variants can be more or less common in a different population, and different groups may need their own specific studies to gain a better global understanding. For example, the NFXL1 variant found to increase risk of DLD on Robinson Crusoe . The availability of 1000
Genomes data has improved power to detect variants that differ in allele frequencies between populations however, these are still limited to relatively small numbers of individuals from a restricted set of countries.
Another degree of complexity is added by tissue specificity; while present in the genomic DNA of every cell, some mutations may only have a detectable effect in a specific tissue, at a particular time in development. The function of a gene can vary between cell types and conditions, and many genes have multiple, and often surprisingly different, functions. FOXP2 is highly expressed in the brain, but is also highly expressed in the lungs and many other tissue types all of which will carry the mutation at a DNA level 70 . The brain appears particularly sensitive to this particularly change and, as far as we are aware, the lungs of the KE family are unaffected 15 . It is therefore important to remember that although genomic technologies can give us a window into what is happening in a particular individual, it is far more challenging to predict the cellular context in which it will become important.
Paleogenetics and Language
In evolutionary terms, the window to understand genetic effects on cognitive function and language ability in hominins is even narrower than in modern humans, and must be interpreted with extreme caution. The humanised version of FOXP2 is thought to have become fixed in the population around 500 KYA, prior to the last shared common ancestor (370-450 KYA) 71 and the presence of this version in Neanderthals supports the notion of cognitive function sophisticated enough to support language. More recently, a regulatory region of FOXP2 was identified exclusively in modern humans at a binding site of the transcription factor POUF3F2 which is absent in Neanderthals 72 . This suggests that differences in gene regulation and expression may be involved in cognitive function, and that species differences are due to far more than just two variants in a single gene. We must be cautious when interpreting such information as it is extremely unlikely that these FOXP2 changes are 14 solely responsible for the presence (or absence) of language function, and any observations, modern or otherwise, should consider the entire genetic background. 73 To further complicate the underlying assumptions in evolutionary studies, the small numbers of Neanderthals sequenced heavily biases the study findings. The difficulties in obtaining ancient DNA of suitable quality for sequencing, means that sequenced individuals are not representative of time periods or geographical locations, and are from a small number of sites where preservation conditions were optimal. As discussed above, genome sequence studies clearly illustrate that small numbers of individuals from one or two geographical locations do not represent the entire population. This is the modern genetic equivalent of sequencing one family and assuming that everyone else is the samethis is not genetically plausible. There is not enough available population data to be able to accurately predict genetic affects, particularly with respect to complex cognitive processes like language function.
Paleogenetics researchers are slowly building a broader and more accurate picture of ancient hominin genetics through sequencing larger numbers from a range of geographical locations. A larger sample size will greatly improve the statistical significance of findings, and increase confidence in their implication for language and higher cognitive function. Genes that are implicated in language disorders in modern can inform investigation of language in ancient hominins, and there have been several efforts to investigate the impact of language associated genes more broadly 73 . Through the expansion of genetic technologies and a greater understanding of their application and limitation, we will continue to build a more accurate picture of both modern and ancient language cognition slowly, piece by piece, applying the scientific rigour and multiple lines of evidence of molecular biology.
Discussion
The study of language disorders has been fruitful in implicating genes, and subsequent molecular pathways that are involved in the mechanisms of language. While there have been many exciting discoveries spanning the past two decades, there remains much more to understand. We still do not 15 fully understand the underlying causes of DLDs, and what makes some children are more susceptible.
Family studies can still provide novel insights into the underlying mechanisms of DLDs. There is strong potential for using a familial shared genetics-based approach, particularly when combined with recent advances in sequencing technologies that can investigate more of the genome than ever before..
We increasingly recognise that genetic risk plays a key role in language disorders and many current approaches are investigating a genetic background of susceptibility. To be statistically sound, these studies require much larger sample sizes and more consistently phenotyped datasets to generate sufficient statistical power. The reality is that DLDs are likely to involve some high impact rare mutations, genetic rearrangements and common sequence variations, all of which create a background of susceptibility. Family based and association studies are still uncovering some unlikely pathways which play a role in language disorders, and it is clear that it will not be a simple story.
The idea that a single gene has a distinct role or confers a single trait is an outdated concept.
Similarly, the idea that a gene will have a single role in the cell has been dispelled. We understand that non-coding variants can play a crucial role in gene regulation, and are highly likely to have an important function in DLDs, and other neurodevelopmental disorders. The genetic background and regulation of gene expression and function is dynamic, and depends greatly on individual cell types.
While this is still poorly understood, methods for detecting and experimentally validating such context dependent states are in development. The function of a gene in a particular cellular circumstance can, and will be validated by molecular biology in model animal or cellular systems.
Genetic control is no longer beyond our testing capability, and we have a range of technologies to characterise gene function and expression across different cell types and under different conditions.
Environmental factors clearly play a role in language development, and poor life circumstance may impact the DLD phenotype. Nature versus nurture is a falsely binary concept, and the underlying genetics plays a key role within an environmental (nurture) context. 16 The theory that the presence of 'humanised' FOXP2 gene in Neanderthals drove language ability is naive and overly simplistic. FOXP2 clearly plays an important role in speech evolution and production, however, we must be cautious to avoid making over-inflated statements about language in Neanderthals based on a single gene 19 . We are only just beginning to unravel the highly complex developmental processes that underlie speech in modern humans, and should be extremely cautious in extrapolating any findings into hominins. The identification of risk factors for DLDs in modern humans will inform our understanding of capacity for language in ancient hominins. We may be able to build a far clearer picture of how language evolved once we increase our understanding of the neuromolecular pathways involved language development in modern humans.
